Reaction

Diabetic Nephropathy reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,185 reports · 85 co-occurring drugs

As of the last recalculation, Diabetic Nephropathy appears in 2,185 FAERS reports alongside 85 co-occurring drug terms. The strongest observed disproportionality signal is LANSOPRAZOLE (PRR 50.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Lansoprazole	661	50.3	50.4
Esomeprazole	194	32.6	32.7
Human Insulin	33	25.5	25.6
Esomeprazole Magnesium	428	21.4	21.5
Esomeprazole Magnesium Capsule, Delayed Release	31	20.6	20.7
Esomeprazole Magnesium Delayed Release Capsules	31	20.6	20.7
Esomeprazole Magnesium Dihydrate	31	20.5	20.6
Ziprasidone Mesylate	30	20.3	20.4
Insulin Glargine-Yfgn	40	17.7	17.8
Olanzapine Pamoate	72	17.3	17.3
Ziprasidone	30	16.4	16.5
Omeprazole Magnesium	554	15.5	15.5
Febuxostat Tablets 40 Mg	16	15.1	15.1
Febuxostat Tablets 80 Mg	16	15.1	15.1
Insulin Human	61	15.0	15.0
Cimetidine	15	14.9	15.0
Glyburide	37	14.8	14.8
Insulin	79	14.0	14.0
Pioglitazone	60	13.6	13.6
Insulin Glulisine	14	13.2	13.2
Pitavastatin Calcium	14	13.1	13.1
Enalapril Maleate	33	12.9	12.9
Omeprazole	380	12.5	12.5
Pantoprazole	287	12.3	12.3
Pantoprazole Sodium	174	12.1	12.1
Dexlansoprazole	51	11.9	11.9
Insulin Aspart	77	11.5	11.5
Nebivolol	19	11.5	11.5
Metolazone	13	11.1	11.1
Gemfibrozil	17	10.7	10.8
Linagliptin	20	10.5	10.5
Sitagliptin	73	9.9	10.0
Febuxostat	17	9.7	9.7
Amlodipine Besylate And Benazepril Hydrochloride	9	9.3	9.3
Basiliximab	11	8.9	9.0
Nifedipine	43	8.8	8.8
Doxazosin Mesylate	33	8.8	8.8
Quetiapine	164	8.7	8.7
Amlodipine Besylate And Valsartan	10	8.6	8.6
Metformin Hydrochloride	52	8.5	8.6
Glimepiride	34	8.4	8.4
Glipizide	52	8.3	8.3
Metformin Hydrochloride Tablets	49	8.3	8.3
Metformin Hydrochloride Extended-Release Tablets	49	8.3	8.3
Metformin Hydrochloride Tablet	49	8.3	8.3
Ezetimibe And Simvastatin	13	8.2	8.2
Telmisartan	15	8.1	8.1
Doxazosin	23	7.9	7.9
Lithium Carbonate	14	7.9	7.9
Insulin Glargine	184	7.7	7.7
Nitroglycerin	42	7.6	7.6
Rabeprazole Sodium	21	7.4	7.4
Divalproex Sodium	35	7.3	7.3
Olanzapine	77	7.0	7.0
Metformin Hcl	40	7.0	7.0
Methoxy Polyethylene Glycol-Epoetin Beta	8	6.9	6.9
Diphenhydramine Hcl	8	6.9	6.9
Insulin Lispro	95	6.8	6.8
Enalapril	38	6.6	6.6
Niacin	8	6.6	6.6
Nebivolol Hydrochloride	23	6.5	6.6
Valsartan And Hydrochlorothiazide	9	6.3	6.3
Sitagliptin And Metformin Hydrochloride	14	6.2	6.2
Olmesartan Medoxomil	23	6.1	6.2
Iron Sucrose	6	6.0	6.0
Abacavir Sulfate	6	5.9	5.9
Sevelamer Carbonate	7	5.8	5.8
Lisinopril And Hydrochlorothiazide	6	5.6	5.6
Insulin Degludec	13	5.3	5.3
Dapagliflozin	17	5.2	5.2
Lisinopril And Hydrochlorothiazide Tablets	4	4.9	4.9
Aripiprazole	60	4.8	4.8
Paricalcitol	7	4.7	4.7
Empagliflozin	31	4.4	4.4
Tenofovir Disoproxil Fumarate Tablets	4	4.4	4.4
Risperidone	59	4.3	4.3
Exenatide	21	3.8	3.8
Ranibizumab	10	3.6	3.6
Liraglutide	18	3.5	3.5
Tolvaptan	5	3.3	3.3
Canagliflozin	10	3.2	3.2
Ledipasvir And Sofosbuvir	5	2.5	2.5
Aflibercept	7	2.1	2.1
Ranitidine Hydrochloride	12	2.1	2.1
Cinacalcet Hydrochloride	5	1.0	1.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.